iifl-logo

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

sidebar image

Strides Pharma's Singapore Arm Receives USFDA Nod for Generic Mycophenolate Mofetil

30 Aug 2023 , 03:27 PM

Strides Pharma Science Ltd’s Singapore subsidiary, Strides Pharma Global Pte. Ltd, secures approval from USFDA for generic Mycophenolate Mofetil. The medication is intended for oral suspension and serves organ transplant patients to prevent rejection.

The approval covers Mycophenolate Mofetil of strength 200 mg/ml, as stated in Strides Pharma Science’s regulatory filing. This generic product is both bioequivalent and therapeutically equivalent to the reference listed drug (RLD) CellCept for oral suspension, with a strength of 200 mg/ml from Roche Palo Alto, LLC.

The approval reinforces Strides’ existing Mycophenolate Mofetil portfolio, which already encompasses several products. Manufacture of the approved product will occur at the company’s Bengaluru facility, according to Strides.

The market size for Mycophenolate Mofetil for oral suspension stands at USD 41 million, based on IQVIA data as noted by the company.

 

For feedback and suggestions, write to us at editorial@iifl.com

 

Related Tags

  • business
  • Company
  • Strides Pharma
  • USFDA
sidebar mobile

BLOGS AND PERSONAL FINANCE

Read More
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.